Oliver von Stein

Amministratore Delegato presso Berlin Cures Holding AG

Health Technology

Commercial Services

Consumer Services

Profilo

Oliver von Stein was the founder and had founded InDex Pharmaceuticals Holding AB in 2000, where he held the title of Chief Scientific Officer from 2009 to 2013.
He is currently the Chief Executive Officer at Berlin Cures Holding AG since 2023.
Dr. von Stein's former positions include Operations Director at Silence Therapeutics Plc from 2014 to 2015 and Project Leader at MediGene AG.
Dr. von Stein holds a doctorate degree from Karlsruher Institut für Technologie.

Posizioni attive di Oliver von Stein

Società	Posizione	Inizio
Berlin Cures Holding AG Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023.	Amministratore Delegato	15/06/2023

Tutte le posizioni attive di Oliver von Stein

Precedenti posizioni note di Oliver von Stein

Società	Posizione	Fine
SILENCE THERAPEUTICS PLC	Direttore operativo	01/08/2015
MEDIGENE AG	Corporate Officer/Principal	-
INDEX PHARMACEUTICALS HOLDING AB	Fondatore	-

Vedi nel dettaglio l'esperienza di Oliver von Stein

Formazione di Oliver von Stein

Karlsruher Institut für Technologie

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Oliver von Stein

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
MEDIGENE AG	Health Technology
SILENCE THERAPEUTICS PLC	Commercial Services
INDEX PHARMACEUTICALS HOLDING AB	Health Technology

Aziende private	1
Berlin Cures Holding AG Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023.	Health Technology